Moore Capital Management LP Sells 379,128 Shares of Teladoc Health, Inc. $TDOC

Moore Capital Management LP decreased its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 93.2% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 27,503 shares of the health services provider’s stock after selling 379,128 shares during the quarter. Moore Capital Management LP’s holdings in Teladoc Health were worth $233,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Two Sigma Securities LLC bought a new stake in Teladoc Health during the second quarter valued at about $290,000. Pin Oak Investment Advisors Inc. bought a new position in shares of Teladoc Health in the second quarter worth about $186,000. Twin Lakes Capital Management LLC purchased a new stake in shares of Teladoc Health during the second quarter worth about $26,000. Empowered Funds LLC purchased a new stake in shares of Teladoc Health during the second quarter worth about $5,765,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Teladoc Health during the 2nd quarter valued at approximately $46,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

NYSE TDOC opened at $6.25 on Wednesday. The stock has a market capitalization of $1.14 billion, a PE ratio of -6.31 and a beta of 2.12. The business has a 50 day simple moving average of $7.89 and a two-hundred day simple moving average of $6.67. Teladoc Health, Inc. has a 1-year low of $4.40 and a 1-year high of $9.89.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.04. The business had revenue of $606.93 million for the quarter, compared to analysts’ expectations of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The company’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.19) EPS. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. On average, analysts anticipate that Teladoc Health, Inc. will post -0.89 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Bank of America boosted their price target on Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a report on Tuesday, July 7th. Citigroup reduced their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Canaccord Genuity Group cut their target price on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Five analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $7.54.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.